Baird raised the firm’s price target on iRhythm (IRTC) to $180 from $160 and keeps an Outperform rating on the shares. The firm updated its model following results as its multi-year growth transformation is beginning to gain steam.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- iRhythm Technologies: Strong Performance and Growth Potential Justify Buy Rating
- iRhythm price target raised to $170 from $139 at Canaccord
- iRhythm price target raised to $190 from $145 at JPMorgan
- Irhythm Technologies: Strong Performance and Growth Potential Drive Buy Rating
- Irhythm Technologies: Strong Performance and Promising Outlook Drive Buy Rating